
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies
Tammy Hod, Aharon Ben‐David, Liraz Olmer, et al.
Transplantation (2021) Vol. 105, Iss. 11, pp. e234-e243
Open Access | Times Cited: 43
Tammy Hod, Aharon Ben‐David, Liraz Olmer, et al.
Transplantation (2021) Vol. 105, Iss. 11, pp. e234-e243
Open Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 390
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 390
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
Simon Galmiche, Liêm Binh Luong Nguyen, Éric Tartour, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 163-177
Open Access | Times Cited: 175
Simon Galmiche, Liêm Binh Luong Nguyen, Éric Tartour, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 163-177
Open Access | Times Cited: 175
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
Luuk Wieske, Koos P J van Dam, Maurice Steenhuis, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 5, pp. e338-e350
Open Access | Times Cited: 111
Luuk Wieske, Koos P J van Dam, Maurice Steenhuis, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 5, pp. e338-e350
Open Access | Times Cited: 111
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
Andrea Antinori, Stefania Cicalini, Silvia Meschi, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e552-e563
Open Access | Times Cited: 110
Andrea Antinori, Stefania Cicalini, Silvia Meschi, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e552-e563
Open Access | Times Cited: 110
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant
Kasama Manothummetha, Nipat Chuleerarux, Anawin Sanguankeo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e226822-e226822
Open Access | Times Cited: 87
Kasama Manothummetha, Nipat Chuleerarux, Anawin Sanguankeo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e226822-e226822
Open Access | Times Cited: 87
The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future
Andrea Antinori, Mary T. Bausch-Jurken
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_1, pp. S4-S12
Open Access | Times Cited: 44
Andrea Antinori, Mary T. Bausch-Jurken
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_1, pp. S4-S12
Open Access | Times Cited: 44
Efficacy of COVID-19 vaccines in immunocompromised patients: A systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 83
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 83
Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis
Mohammad-Mehdi Mehrabi Nejad, Fatemeh Moosaie, Hojat Dehghanbanadaki, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 52
Mohammad-Mehdi Mehrabi Nejad, Fatemeh Moosaie, Hojat Dehghanbanadaki, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 52
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis
Xinpei Chen, De Luo, Bingjie Mei, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 4, pp. 441-456
Open Access | Times Cited: 44
Xinpei Chen, De Luo, Bingjie Mei, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 4, pp. 441-456
Open Access | Times Cited: 44
Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis
Jiajing Li, Ibrahim Ayada, Yining Wang, et al.
Transplantation (2022) Vol. 106, Iss. 10, pp. 2068-2075
Open Access | Times Cited: 32
Jiajing Li, Ibrahim Ayada, Yining Wang, et al.
Transplantation (2022) Vol. 106, Iss. 10, pp. 2068-2075
Open Access | Times Cited: 32
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis
Hari Shankar Meshram, Vivek Kute, Hemant Rane, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 30
Hari Shankar Meshram, Vivek Kute, Hemant Rane, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 30
Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis
Mohammad-Mehdi Mehrabi Nejad, Parnian Shobeiri, Hojat Dehghanbanadaki, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 24
Mohammad-Mehdi Mehrabi Nejad, Parnian Shobeiri, Hojat Dehghanbanadaki, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 24
BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients
Tammy Hod, Aharon Ben‐David, Liraz Olmer, et al.
Transplant International (2022) Vol. 35
Open Access | Times Cited: 23
Tammy Hod, Aharon Ben‐David, Liraz Olmer, et al.
Transplant International (2022) Vol. 35
Open Access | Times Cited: 23
Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine
Magdalena Piotrowska, Maciej Zieliński, Leszek Tylicki, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Magdalena Piotrowska, Maciej Zieliński, Leszek Tylicki, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Dynamics of SARS-CoV-2-Spike-reactive antibody and T-cell responses in chronic kidney disease patients within 3 months after COVID-19 full vaccination
Nayara Panizo, Eliseo Albert, Elena Giménez-Civera, et al.
Clinical Kidney Journal (2022) Vol. 15, Iss. 8, pp. 1562-1573
Open Access | Times Cited: 19
Nayara Panizo, Eliseo Albert, Elena Giménez-Civera, et al.
Clinical Kidney Journal (2022) Vol. 15, Iss. 8, pp. 1562-1573
Open Access | Times Cited: 19
Risk Factors for Weak Antibody Response of SARS-CoV-2 Vaccine in Adult Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis
Kezhen Zong, Dadi Peng, Hang Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Kezhen Zong, Dadi Peng, Hang Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Antibody Response to mRNA Vaccines against SARS-CoV-2 with Chronic Kidney Disease, Hemodialysis, and after Kidney Transplantation
Lukas Buchwinkler, Claire Anne Solagna, Janosch Messner, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 148-148
Open Access | Times Cited: 22
Lukas Buchwinkler, Claire Anne Solagna, Janosch Messner, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 148-148
Open Access | Times Cited: 22
COVID-19 mortality may be reduced among fully vaccinated solid organ transplant recipients
Micaela Sandoval, Duc T. Nguyen, Howard J. Huang, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0279222-e0279222
Open Access | Times Cited: 15
Micaela Sandoval, Duc T. Nguyen, Howard J. Huang, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0279222-e0279222
Open Access | Times Cited: 15
Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients
Sabina Herrera, José María Aguado, Francisco Javier Candel, et al.
Transplantation Reviews (2023) Vol. 37, Iss. 4, pp. 100788-100788
Closed Access | Times Cited: 7
Sabina Herrera, José María Aguado, Francisco Javier Candel, et al.
Transplantation Reviews (2023) Vol. 37, Iss. 4, pp. 100788-100788
Closed Access | Times Cited: 7
Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis
Abdulmalik S. Alotaibi, Heba A. Shalabi, Abdullah A. Alhifany, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1166-1166
Open Access | Times Cited: 6
Abdulmalik S. Alotaibi, Heba A. Shalabi, Abdullah A. Alhifany, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1166-1166
Open Access | Times Cited: 6
An Analysis of Serological Response and Infection Outcomes Following Oxford-AstraZeneca (AZD1222) and Pfizer-BioNTech (mRNA BNT162b2) SARS-CoV-2 Vaccines in Kidney and Kidney-pancreas Transplants
Argiris Asderakis, Usman Khalid, Georgios Koimtzis, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. 1421-1429
Open Access | Times Cited: 10
Argiris Asderakis, Usman Khalid, Georgios Koimtzis, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. 1421-1429
Open Access | Times Cited: 10
Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls
Daniel Balsby, Anna Christine Nilsson, Inge Petersen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Daniel Balsby, Anna Christine Nilsson, Inge Petersen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Humoral Response to the Fourth BNT162b2 Vaccination and Link Between the Fourth Dose, Omicron Infection, and Disease Severity in Renal Transplant Recipients
Tammy Hod, Aharon Ben‐David, Eytan Mor, et al.
Transplantation (2022) Vol. 107, Iss. 1, pp. 192-203
Open Access | Times Cited: 8
Tammy Hod, Aharon Ben‐David, Eytan Mor, et al.
Transplantation (2022) Vol. 107, Iss. 1, pp. 192-203
Open Access | Times Cited: 8
Seroconversion rates in kidney transplant recipients following SARS-CoV-2 vaccination and its association with immunosuppressive agents: a systematic review and meta-analysis
Maria Riastuti Iryaningrum, Alius Cahyadi, Fachreza Aryo Damara, et al.
Clinical and Experimental Vaccine Research (2023) Vol. 12, Iss. 1, pp. 13-13
Open Access | Times Cited: 4
Maria Riastuti Iryaningrum, Alius Cahyadi, Fachreza Aryo Damara, et al.
Clinical and Experimental Vaccine Research (2023) Vol. 12, Iss. 1, pp. 13-13
Open Access | Times Cited: 4
Humoral Response After Five Successive Doses of SARS-CoV-2 mRNA Vaccine in Kidney Transplant Patients
Juan Manuel Cazorla, Florentino Villanego, Aurora Aguilera, et al.
Transplantation (2023) Vol. 107, Iss. 7, pp. e188-e189
Open Access | Times Cited: 4
Juan Manuel Cazorla, Florentino Villanego, Aurora Aguilera, et al.
Transplantation (2023) Vol. 107, Iss. 7, pp. e188-e189
Open Access | Times Cited: 4